Literature DB >> 18262639

Linezolid for treatment of subdural empyema due to Streptococcus: case reports.

Laurent Lefebvre1, Philippe Metellus, Henry Dufour, Nicolas Bruder.   

Abstract

BACKGROUND: Recurring subdural empyema despite adequate surgical drainage and antibiotic treatment is still a life-threatening disease. This is mainly due to poor diffusion of the antibiotic into the subdural space. CASE DESCRIPTION: We report 2 cases of recurring subdural empyema due to Streptococcus, after repeat surgery and high-dose antibiotic treatment including beta-lactamines and vancomycin. Both patients showed marked clinical and radiologic improvement after introduction of linezolid. There was no drug-related adverse effect despite 36 and 90 days of treatment.
CONCLUSION: Off-label use of linezolid for treatment of subdural empyema due to gram-positive bacteria should be considered after failure of conventional antibiotic treatment.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18262639     DOI: 10.1016/j.surneu.2007.06.083

Source DB:  PubMed          Journal:  Surg Neurol        ISSN: 0090-3019


  3 in total

1.  Subdural empyema due to mixed infections successfully treated medically: A case report with review literature.

Authors:  Mostafa Meshref; Anas Zakarya Nourelden; Alaa Ahmed Elshanbary; Yossef Hassan AbdelQadir; Mohamed Sayed Zaazouee; Khaled Mohamed Ragab; Eman Mohammed Sharif Ahmed; Sarya Swed
Journal:  Clin Case Rep       Date:  2022-07-14

Review 2.  Subdural empyema in children.

Authors:  Dattatraya Muzumdar; Naresh Biyani; Chandrashekhar Deopujari
Journal:  Childs Nerv Syst       Date:  2018-07-16       Impact factor: 1.475

Review 3.  Subdural empyema in children.

Authors:  Mohammed A Hendaus
Journal:  Glob J Health Sci       Date:  2013-08-14
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.